Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Izawa

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Archives of Neurology|July 11, 2012
Hypothermia, hypotension, hypersomnia, and obesity associated with hypothalamic lesions in a patient positive for the anti-aquaporin 4 antibody: a case report and literature reviewKeisuke Suzuki, Toshiki Nakamura, Kenichi Hashimoto, et al.
Oncology|June 14, 2019
Clinical Implications of Decreased Computed Tomography Value after Ramucirumab in Advanced Gastric CancerNaoki Izawa, Yu Sunakawa, Ayako Doi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 19, 2022
[A Case of Unresectable Gastric Cancer Who Underwent Conversion Surgery after SP Therapy and Achieved Long-Term Survival]Shimpei Takagi, Shinya Mikami, Yuki Amano, et al.
Investigational New Drugs|April 26, 2019
Phase I study of the anti-heparin-binding epidermal growth factor-like growth factor antibody U3-1565 with cetuximab in patients with cetuximab- or panitumumab-resistant metastatic colorectal cancerTakako Eguchi Nakajima, Narikazu Boku, Ayako Doi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2020
Multicenter Phase I/II Study of Nivolumab Combined with Paclitaxel Plus Ramucirumab as Second-line Treatment in Patients with Advanced Gastric CancerTakako Eguchi Nakajima, Shigenori Kadowaki, Keiko Minashi, et al.
Oncotarget|January 5, 2018
Early morphological change for predicting outcome in metastatic colorectal cancer after regorafenibHiroyuki Arai, Kunihisa Miyakawa, Tadamichi Denda, et al.
Molecular and Clinical Oncology|April 14, 2016
Infusion site adverse events in breast cancer patients receiving highly emetic chemotherapy with prophylactic anti-emetic treatment with aprepitant and fosaprepitant: A retrospective comparisonTakashi Tsuda, Chisato Kyomori, Takuro Mizukami, et al.
Annals of Gastroenterological Surgery|November 6, 2024
Phase II study of long-course chemoradiotherapy followed by consolidation chemotherapy as total neoadjuvant therapy in locally advanced rectal cancer in Japan: ENSEMBLE-2Yoshinori Kagawa, Koji Ando, Mamoru Uemura, et al.
Esophagus : Official Journal of the Japan Esophageal Society|September 12, 2019
Analysis of fistula formation of T4 esophageal cancer patients treated by chemoradiotherapyTomoko Katsui Taniyama, Takashi Tsuda, Kunihisa Miyakawa, et al.
Targeted Oncology|April 2, 2022
Clinical Utility of Genomic Profiling Tests in Patients with Advanced Gastrointestinal CancersHiroyuki Takeda, Kiyomi Imoto, Kumiko Umemoto, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Archives of Neurology|July 11, 2012
Hypothermia, hypotension, hypersomnia, and obesity associated with hypothalamic lesions in a patient positive for the anti-aquaporin 4 antibody: a case report and literature reviewKeisuke Suzuki, Toshiki Nakamura, Kenichi Hashimoto, et al.
Oncology|June 14, 2019
Clinical Implications of Decreased Computed Tomography Value after Ramucirumab in Advanced Gastric CancerNaoki Izawa, Yu Sunakawa, Ayako Doi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 19, 2022
[A Case of Unresectable Gastric Cancer Who Underwent Conversion Surgery after SP Therapy and Achieved Long-Term Survival]Shimpei Takagi, Shinya Mikami, Yuki Amano, et al.
Investigational New Drugs|April 26, 2019
Phase I study of the anti-heparin-binding epidermal growth factor-like growth factor antibody U3-1565 with cetuximab in patients with cetuximab- or panitumumab-resistant metastatic colorectal cancerTakako Eguchi Nakajima, Narikazu Boku, Ayako Doi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2020
Multicenter Phase I/II Study of Nivolumab Combined with Paclitaxel Plus Ramucirumab as Second-line Treatment in Patients with Advanced Gastric CancerTakako Eguchi Nakajima, Shigenori Kadowaki, Keiko Minashi, et al.
Oncotarget|January 5, 2018
Early morphological change for predicting outcome in metastatic colorectal cancer after regorafenibHiroyuki Arai, Kunihisa Miyakawa, Tadamichi Denda, et al.
Molecular and Clinical Oncology|April 14, 2016
Infusion site adverse events in breast cancer patients receiving highly emetic chemotherapy with prophylactic anti-emetic treatment with aprepitant and fosaprepitant: A retrospective comparisonTakashi Tsuda, Chisato Kyomori, Takuro Mizukami, et al.
Annals of Gastroenterological Surgery|November 6, 2024
Phase II study of long-course chemoradiotherapy followed by consolidation chemotherapy as total neoadjuvant therapy in locally advanced rectal cancer in Japan: ENSEMBLE-2Yoshinori Kagawa, Koji Ando, Mamoru Uemura, et al.
Esophagus : Official Journal of the Japan Esophageal Society|September 12, 2019
Analysis of fistula formation of T4 esophageal cancer patients treated by chemoradiotherapyTomoko Katsui Taniyama, Takashi Tsuda, Kunihisa Miyakawa, et al.
Targeted Oncology|April 2, 2022
Clinical Utility of Genomic Profiling Tests in Patients with Advanced Gastrointestinal CancersHiroyuki Takeda, Kiyomi Imoto, Kumiko Umemoto, et al.
Pageof 7